• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-核糖:在充血性心力衰竭和糖尿病及其并发症中的潜在临床应用(综述)

D-ribose: Potential clinical applications in congestive heart failure and diabetes, and its complications (Review).

作者信息

Li Shuai, Wang Juanjing, Xiao Yutian, Zhang Li, Fang Jinren, Yang Nanyang, Zhang Zhixia, Nasser Moussa Ide, Qin Hui

机构信息

Institute of Cytology and Genetics, Hengyang Medical College, University of South China, Hengyang, Hunan 421000, P.R. China.

School of Pharmaceutical Science, University of South China, Hengyang, Hunan 421000, P.R. China.

出版信息

Exp Ther Med. 2021 May;21(5):496. doi: 10.3892/etm.2021.9927. Epub 2021 Mar 17.

DOI:10.3892/etm.2021.9927
PMID:33791005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8005739/
Abstract

The quality of life of patients with certain diseases may be improved through the development of technologies and advancements in pharmacology, with the aim of prolonging their life. However, congestive heart failure (CHF), as well their complications, continue to be the leading cause of disease-associated death. The mechanisms underlying the development and progression of diabetes and CHF have been uncovered in a stepwise manner and the understanding of these mechanisms has improved the management of these diseases, resulting in reduced mortality and morbidity rates; however, CHF remains the leading cause of death worldwide, particularly in developed countries. In the past decades, research has indicated that several supplements and naturally occurring compounds may be used to treat muscle weakness, for cardiac failure management, rehabilitation following myocardial ischemia-reperfusion and various complications of diabetes. D-ribose is an essential component of the respiratory, skeletal and nervous systems and is a popular compound, as its supplementation may have beneficial effects. In the present review, the physiological roles, toxic reactions and the potential use of D-ribose in the management of clinical diseases are summarized.

摘要

通过技术发展和药理学进步,某些疾病患者的生活质量可能会得到改善,目的是延长他们的生命。然而,充血性心力衰竭(CHF)及其并发症仍然是疾病相关死亡的主要原因。糖尿病和CHF发生及进展的潜在机制已逐步被揭示,对这些机制的理解改善了这些疾病的管理,导致死亡率和发病率降低;然而,CHF仍然是全球尤其是发达国家的主要死亡原因。在过去几十年中,研究表明,几种补充剂和天然存在的化合物可用于治疗肌肉无力、管理心力衰竭、心肌缺血再灌注后的康复以及糖尿病的各种并发症。D-核糖是呼吸、骨骼和神经系统的重要组成部分,是一种受欢迎的化合物,因为补充它可能有有益作用。在本综述中,总结了D-核糖的生理作用、毒性反应及其在临床疾病管理中的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4237/8005739/db203b048af8/etm-21-05-09927-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4237/8005739/8f3590e1ad17/etm-21-05-09927-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4237/8005739/7727f2f7d46e/etm-21-05-09927-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4237/8005739/db203b048af8/etm-21-05-09927-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4237/8005739/8f3590e1ad17/etm-21-05-09927-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4237/8005739/7727f2f7d46e/etm-21-05-09927-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4237/8005739/db203b048af8/etm-21-05-09927-g02.jpg

相似文献

1
D-ribose: Potential clinical applications in congestive heart failure and diabetes, and its complications (Review).D-核糖:在充血性心力衰竭和糖尿病及其并发症中的潜在临床应用(综述)
Exp Ther Med. 2021 May;21(5):496. doi: 10.3892/etm.2021.9927. Epub 2021 Mar 17.
2
D-ribose, a metabolic substrate for congestive heart failure.D-核糖,一种用于充血性心力衰竭的代谢底物。
Prog Cardiovasc Nurs. 2009 Jun;24(2):59-60. doi: 10.1111/j.1751-7117.2009.00033.x.
3
D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study.D-核糖改善充血性心力衰竭患者的舒张功能和生活质量:一项前瞻性可行性研究。
Eur J Heart Fail. 2003 Oct;5(5):615-9. doi: 10.1016/s1388-9842(03)00060-6.
4
Correlation of the Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure.医疗保健政策与研究机构充血性心力衰竭入院指南与死亡率的相关性:同行评审组织自愿医院协会降低充血性心力衰竭事件的倡议(PROVIDE)
Ann Emerg Med. 1999 Oct;34(4 Pt 1):429-37. doi: 10.1016/s0196-0644(99)80043-2.
5
Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?溴苄铵对室颤、急性心肌梗死(心肌坏死)、心力衰竭及死亡率的预防作用:缺血性心脏病主要是肾上腺素能心血管疾病吗?
Am J Ther. 2004 Sep-Oct;11(5):366-411. doi: 10.1097/01.mjt.0000126444.24163.81.
6
The patented uses of D-ribose in cardiovascular diseases.D-核糖在心血管疾病中的专利用途。
Recent Pat Cardiovasc Drug Discov. 2010 Jun;5(2):138-42. doi: 10.2174/157489010791515241.
7
Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.促红细胞生成素在心力衰竭及其他心血管疾病中的作用:造血及多效性效应
Curr Drug Targets Cardiovasc Haematol Disord. 2005 Oct;5(5):355-75. doi: 10.2174/156800605774370326.
8
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model.急性心肌梗死溶栓治疗后发生充血性心力衰竭患者的临床特征及长期预后:预测模型的建立
Am Heart J. 1997 Jun;133(6):663-73. doi: 10.1016/s0002-8703(97)70168-6.
9
Congestive heart failure in children with pneumonia and respiratory failure.肺炎合并呼吸衰竭患儿的充血性心力衰竭
Pediatr Int. 2017 Mar;59(3):258-264. doi: 10.1111/ped.13153. Epub 2016 Nov 6.
10
Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?药物、心力衰竭与生活质量:我们取得了哪些成果?我们应努力实现什么目标?
Drugs Aging. 1999 Mar;14(3):153-63. doi: 10.2165/00002512-199914030-00001.

引用本文的文献

1
RIBOsensor for FRET-based, real-time ribose measurements in live cells.用于在活细胞中基于荧光共振能量转移(FRET)进行实时核糖测量的核糖传感器。
Chem Sci. 2025 Apr 8;16(18):8125-8135. doi: 10.1039/d5sc00244c. eCollection 2025 May 7.
2
Oral ribose supplementation in dystroglycanopathy: A single case study.口服核糖补充剂治疗糖基化肌营养不良症:一项单病例研究。
JIMD Rep. 2024 Mar 4;65(3):171-181. doi: 10.1002/jmd2.12394. eCollection 2024 May.
3
D-ribose metabolic disorder and diabetes mellitus.D-核糖代谢紊乱与糖尿病。

本文引用的文献

1
The Optimized Calculation Method for Insulin Dosage in an Insulin Tolerance Test (ITT): A Randomized Parallel Control Study.胰岛素耐量试验中胰岛素剂量优化计算方法:一项随机平行对照研究。
Front Endocrinol (Lausanne). 2020 Apr 9;11:202. doi: 10.3389/fendo.2020.00202. eCollection 2020.
2
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety.用于心血管疾病的草药医学:疗效、作用机制与安全性。
Front Pharmacol. 2020 Apr 7;11:422. doi: 10.3389/fphar.2020.00422. eCollection 2020.
3
D-ribose and pathogenesis of Alzheimer's disease.
Mol Biol Rep. 2024 Jan 28;51(1):220. doi: 10.1007/s11033-023-09076-y.
4
Biological Characterization of L. for Phytochemical and Pharmacological Activities in Swiss Albino Mice Model.瑞士白化小鼠模型中L.的植物化学和药理活性的生物学特性
Plants (Basel). 2023 Mar 27;12(7):1455. doi: 10.3390/plants12071455.
5
Produce D-allulose from non-food biomass by integrating corn stalk hydrolysis with whole-cell catalysis.通过将玉米秸秆水解与全细胞催化相结合,从非粮食生物质中生产D-阿洛酮糖。
Front Bioeng Biotechnol. 2023 Feb 24;11:1156953. doi: 10.3389/fbioe.2023.1156953. eCollection 2023.
6
Ribose Intake as Food Integrator: Is It a Really Convenient Practice?核糖摄取作为食物整合剂:这真的是一种方便的做法吗?
Biomolecules. 2022 Nov 29;12(12):1775. doi: 10.3390/biom12121775.
7
A systematic review and meta-analysis of cognitive and behavioral tests in rodents treated with different doses of D-ribose.对用不同剂量D-核糖处理的啮齿动物进行认知和行为测试的系统评价与荟萃分析。
Front Aging Neurosci. 2022 Nov 9;14:1036315. doi: 10.3389/fnagi.2022.1036315. eCollection 2022.
8
Mitochondrial bioenergetics and D-ribose in HFpEF: a brief narrative review.射血分数保留的心力衰竭中的线粒体生物能量学与D-核糖:一篇简要叙述性综述
Ann Transl Med. 2021 Oct;9(19):1504. doi: 10.21037/atm-21-2291.
9
Identification of the Protein Glycation Sites in Human Myoglobin as Rapidly Induced by d-Ribose.鉴定人肌红蛋白中由 d-核糖快速诱导的蛋白质糖化位点。
Molecules. 2021 Sep 26;26(19):5829. doi: 10.3390/molecules26195829.
D-核糖与阿尔茨海默病的发病机制。
Mol Biol Rep. 2020 Mar;47(3):2289-2299. doi: 10.1007/s11033-020-05243-7. Epub 2020 Jan 13.
4
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effectiveness of a Food Supplement Containing Creatine and D-Ribose Combined with a Physical Exercise Program in Increasing Stress Tolerance in Patients with Ischemic Heart Disease.一项随机、双盲、安慰剂对照研究,评估含有肌酸和 D-核糖的食品补充剂与体育锻炼方案相结合对提高缺血性心脏病患者应激耐受力的有效性。
Nutrients. 2019 Dec 17;11(12):3075. doi: 10.3390/nu11123075.
5
Ribosylation-Derived Advanced Glycation End Products Induce Tau Hyperphosphorylation Through Brain-Derived Neurotrophic Factor Reduction.核糖基化衍生的晚期糖基化终产物通过脑源性神经营养因子减少诱导 Tau 过度磷酸化。
J Alzheimers Dis. 2019;71(1):291-305. doi: 10.3233/JAD-190158.
6
Combinational drug-loaded lipid nanocapsules for the treatment of cancer.载药脂质纳米胶囊联合用于癌症治疗。
Int J Pharm. 2019 Oct 5;569:118588. doi: 10.1016/j.ijpharm.2019.118588. Epub 2019 Aug 1.
7
D-ribose is elevated in T1DM patients and can be involved in the onset of encephalopathy.1型糖尿病患者体内的D-核糖水平升高,且其可能与脑病的发病有关。
Aging (Albany NY). 2019 Jul 15;11(14):4943-4969. doi: 10.18632/aging.102089.
8
d-Ribose contributes to the glycation of serum protein.d-核糖会促进血清蛋白的糖化。
Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2285-2292. doi: 10.1016/j.bbadis.2019.05.005. Epub 2019 May 11.
9
Protective Effects of Kaempferol on D-Ribose-Induced Mesangial Cell Injury.山奈酚对 D-核糖诱导的肾小球系膜细胞损伤的保护作用。
Oxid Med Cell Longev. 2019 Mar 31;2019:7564207. doi: 10.1155/2019/7564207. eCollection 2019.
10
A View Beyond HbA1c: Role of Continuous Glucose Monitoring.糖化血红蛋白之外的视角:持续葡萄糖监测的作用
Diabetes Ther. 2019 Jun;10(3):853-863. doi: 10.1007/s13300-019-0619-1. Epub 2019 Apr 29.